Cure My Disease

Don't miss your cure!

 Log in / Sign up

Peanut allergy patch enters human safety trials

NCT ID NCT07580898

Recruiting now Disease control Sponsor: Moonlight Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 5 times

Summary

This early-stage trial is testing whether a microneedle patch called MOON101, which delivers tiny amounts of peanut protein into the skin, is safe for people with peanut allergies. The study will enroll 40 participants, including adults, teenagers, and children. Each person will receive both the active patch and a placebo patch to compare side effects. The main goal is to check for any harmful reactions and find the highest dose that people can tolerate without serious symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
peanut extract applied via a microneedle stamp
What this could lead to
If safe, this could pave the way for a treatment that reduces peanut allergy reactions.
What could go wrong
This is an early Phase 1 safety study with only 40 people, so it may not lead to an effective treatment. Allergic reactions to the patch itself are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEANUT ALLERGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

food allergy Peanut Hypersensitivity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PEANUT ALLERGY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Arkansas Children's Research Institute

    RECRUITING

    Little Rock, Arkansas, 72202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Children's Healthcare of Atlanta

    RECRUITING

    Atlanta, Georgia, 30329, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Dr. Vince Clinical Research

    RECRUITING

    Overland Park, Kansas, 66212, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Michigan

    RECRUITING

    Ann Arbor, Michigan, 48106, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of North Carolina at Chapel Hill

    RECRUITING

    Chapel Hill, North Carolina, 27599, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.